Team:UCSF/Parts1
From 2013.igem.org
(Difference between revisions)
Line 532: | Line 532: | ||
</p1> | </p1> | ||
</div> | </div> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
<!------------------------------------End Context-------------------------------------> | <!------------------------------------End Context-------------------------------------> | ||
Line 544: | Line 538: | ||
</body> | </body> | ||
</html> | </html> | ||
+ | |||
+ | <td valign="top" width="750"> | ||
+ | |||
+ | __NOTOC__ | ||
+ | <center> | ||
+ | <groupparts>iGEM013 UCSF</groupparts> </center> |
Revision as of 17:39, 28 October 2013
BioBrick Parts Submitted to or Characterized in the Registry
Promoters
1. Part: BBa_R0011, Link: pLAC
2. Part: BBa_R0040, Link: pTET
Guide RNAs (gRNA) for CRISPRi
See the chart below for links to the parts registry pages for the RFP, GFP, XylE, and LacZ targeting gRNAs.
CDC sets threat levels for drug-resistant 'superbugs'
Agricultural Antibiotic Use Contributes To 'Super-Bugs' In Humans
<td valign="top" width="750">